The Chemerin Receptor CMKLR1 Requires Full‐Length Chemerin for High Affinity in Contrast to GPR1 as Demonstrated by a New Nanoluciferase‐Based Binding Assay

por Czerniak, Anne Sophie, Kretschmer, Kevin, Weiß, Tina, Beck‐Sickinger, Annette G.
Publicado 2022

Cyclic Derivatives of the Chemerin C-Terminus as Metabolically Stable Agonists at the Chemokine-like Receptor 1 for Cancer Treatment

por Fischer, Tobias F., Czerniak, Anne S., Weiß, Tina, Zellmann, Tristan, Zielke, Lina, Els-Heindl, Sylvia, Beck-Sickinger, Annette G.
Publicado 2021

Dose Variations Using an X-Ray Cabinet to Establish in vitro Dose-Response Curves for Biological Dosimetry Assays

por Bucher, Martin, Weiss, Tina, Endesfelder, David, Trompier, Francois, Ristic, Yoann, Kunert, Patrizia, Schlattl, Helmut, Giussani, Augusto, Oestreicher, Ursula
Publicado 2022

Ligand-binding and -scavenging of the chemerin receptor GPR1

por Fischer, Tobias F., Czerniak, Anne S., Weiß, Tina, Schoeder, Clara T., Wolf, Philipp, Seitz, Oliver, Meiler, Jens, Beck-Sickinger, Annette G.
Publicado 2021

Structural basis of CMKLR1 signaling induced by chemerin9

por Zhang, Xuan, Weiß, Tina, Cheng, Mary Hongying, Chen, Siqi, Ambrosius, Carla Katharina, Czerniak, Anne Sophie, Li, Kunpeng, Feng, Mingye, Bahar, Ivet, Beck-Sickinger, Annette G., Zhang, Cheng
Publicado 2023